Zymeworks Inks $8.1M
Vancouver-based Zymeworks Inc., a biotech company focused on protein-based therapeutics, has raised a total of $8.1 million. CTI Life Sciences Fund and Advanced Biotechnologies Venture Fund are among the investors. The money will be used for continued development.
22 September 2011•3 mins read
